
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells
Author(s) -
André Fedier,
Konstantin J. Dedes,
Patrick Imesch,
André O. von Bueren,
Daniel Fink
Publication year - 2007
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.31.3.633
Subject(s) - vorinostat , histone deacetylase inhibitor , histone deacetylase , apoptosis , cell cycle , cancer research , cell cycle checkpoint , clonogenic assay , valproic acid , pharmacology , biology , hydroxamic acid , multiple drug resistance , chemistry , histone , drug resistance , biochemistry , stereochemistry , microbiology and biotechnology , neuroscience , gene , epilepsy